Related Experiment Video

Updated: Jun 10, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Normal life expectancy after all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia

A Piciocchi¹, A Talone², M Messina²

¹Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy. a.piciocchi@gimema.it.

|June 8, 2026

Abstract

No abstract available in PubMed .

More Related Videos

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Current management and emerging pharmacotherapeutic strategies in acute promyelocytic leukemia.

Expert opinion on pharmacotherapy·2026

Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.

OncoTargets and therapy·2026

IL-5 biology and eosinophil regulation: Advances, resistance pathways and future directions.

Respiratory medicine·2026

The Dysregulation of the Integrated Stress Response in Leukemic Stem Cells as a Marker of Treatment Sensitivity in Acute Myeloid Leukemia.

Genes·2026

FLT3-ITD Measurable Residual Disease in Acute Myeloid Leukemia: Implications for FLT3 Inhibitor-Based Therapies.

Cancers·2026

Is There Still a Role for Autologous Stem Cell Transplantation in Older Adults with AML?

Hematology reports·2026

See all related articles